CME Group (NASDAQ:CME) Earns Sell Rating from Rosenblatt Securities

Rosenblatt Securities restated their sell rating on shares of CME Group (NASDAQ:CME – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $180.00 price target on the financial services provider’s stock. Other analysts have also issued reports about the company. Barclays dropped their price target on CME […]

Leave a Reply

Your email address will not be published.

Previous post TD Cowen Begins Coverage on Stifel Financial (NYSE:SF)
Next post Top oil exporter cuts prices – media